Insight Search

Sort by:
  • Client Story

    October 18, 2021
    Organizations in the managed healthcare sector contend with ongoing claims payment challenges, among many others. Fragmented systems, manual claim auditing, payment errors and tedious reporting drain countless employee hours, and relentless regulatory demands bring pressures daily. As a result, managed care companies are understandably thirsty for ways to relieve the claims audit burden, even as…
  • Survey

    March 10, 2023
    The level of uncertainty in today’s global marketplace and the velocity of change continue to produce a multitude of potential risks that can disrupt an organization’s business model and strategy on very short notice. Unfolding events in Eastern Europe, changes in government leadership in several countries around the globe, escalating inflation, rising interest rates, ever-present cyber threats,…
  • Podcast

    July 24, 2024
    In this episode of Board Perspectives, Sam Stark of Green Project and Michael Vigario of ACT Commodities join Protiviti’s Alyse Mauro Mason to discuss emissions reporting and demystify some of the common fears and misinterpretations in the market. They also talk about areas of opportunity for organizations.
  • Survey

    November 17, 2021
    Protiviti’s Guide to U.S. Anti-Money Laundering Requirements, Frequently Asked Questions provides responses to nearly 3,000 questions aggregated from our clients, attorneys, regulators, members of law enforcement, academics and others interested in the requirements and challenges that companies face in addressing the complex and dynamic topics of anti-money laundering/combatting financial…
  • Whitepaper

    February 22, 2021
    Big changes are coming to how the insurance industry recognizes and reports out financial performance. But the effects won’t be felt just in the accounting department. IFRS 17, Insurance Contracts, and its U.S. companion, accounting standard ASU 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts, are intended to add clarity for investors in the wake of events and…
  • Survey

    May 29, 2023
    The level of uncertainty in today’s global marketplace and the velocity of change continue to produce a multitude of potential risks that can disrupt an organization’s business model and strategy on very short notice. Unfolding events in Eastern Europe, changes in government leadership in several countries around the globe, escalating inflation, rising interest rates, ever-present cyber threats,…
  • Client Story

    March 17, 2021
    The impending retirements of two key executives would constitute a significant disruption for any enterprise. It’s even more disruptive when the business’s legacy customer relationship management (CRM) system was home-built by the departing CIO, and other legacy systems split customer data into separate collections. Under such circumstances, a few agile interventions might be called for. As with…
  • Whitepaper

    October 13, 2021
    Safer supply chain, more information sharing, additional compliance Having faced more cyberattacks than other sectors, banks and other financial services firms have been at the forefront of the fight against cybercrime in recent years. To protect themselves, banks have substantially invested in cyberattack prevention and increased their incidence-response capabilities.
  • Whitepaper

    February 24, 2021
    President Lyndon B. Johnson in 1968 signed the Federal Truth in Lending Act (TILA) to provide greater transparency regarding credit terms and fees. While greatly assisting consumers in comparison loan shopping, the regulation excluded business loans, as business owners were generally considered financially savvier than an average consumer and did not need protection. Fast-forward to December 23,…
  • Client Story

    March 27, 2020
    For one global biopharmaceutical company, the ability to access vital data when and where it’s needed can affect more than just performance — it can impact the ability to save lives. This industry leader develops, manufactures and distributes breakthrough medical therapies to treat patients with serious and life-threatening medical conditions. The company conducts clinical trials to better…
Loading...